Dyax Corp. to Host First Quarter Conference Call

Apr 18, 2001, 01:00 ET from Dyax Corp.

    CAMBRIDGE, Mass., April 18 /PRNewswire/ -- Dyax Corp. (Nasdaq:   DYAX) today
 announced that the company will host a conference call and question and answer
 session on Thursday, April 26, 2001, to discuss the financial results for the
 first quarter of 2001.
 
     Date:           Thursday, April 26, 2001
     Time:           10:00 am Eastern
     Internet:       The event Webcast can be accessed from the Investor
                     Relations page on Dyax's corporate web site at
                     www.dyax.com
     Telephone:      (800) 238-9007
                     International callers, dial (719) 457-2622
                     Access code: 750508
 
     A replay of the conference call will be available for one week following
 the call and can be accessed by dialing (888) 203-1112.  International callers
 should dial (719) 457-0820.  The replay access code is 750508.  The Webcast
 will be archived on the Investor Relations page on Dyax's corporate web site
 at www.dyax.com.
     Dyax Corp. is a biopharmaceutical company that has developed and patented
 phage display technology with applications in the discovery and development of
 a broad range of compounds for the treatment and diagnosis of diseases and for
 the purification and manufacture of biopharmaceuticals and other chemicals.
 Through the use of phage display technology, Dyax's scientists, collaborators
 and licensees seek to discover peptides and proteins, including human
 antibodies, that bind tightly to specific molecular targets.  The Company,
 through a subsidiary, also develops, manufactures and sells chromatography
 separations systems and products under the Biotage trade name.
 
      Contact:
      Jessica Wolfe
      Director, Investor Relations
      Dyax Corp.
      (617) 225-2500
      jwolfe@dyax.com
 
      Doug MacDougall
      Kari Lampka
      Feinstein Kean Healthcare
      (617) 577-8110
      klampka@fkhealth.com
 
 

SOURCE Dyax Corp.
    CAMBRIDGE, Mass., April 18 /PRNewswire/ -- Dyax Corp. (Nasdaq:   DYAX) today
 announced that the company will host a conference call and question and answer
 session on Thursday, April 26, 2001, to discuss the financial results for the
 first quarter of 2001.
 
     Date:           Thursday, April 26, 2001
     Time:           10:00 am Eastern
     Internet:       The event Webcast can be accessed from the Investor
                     Relations page on Dyax's corporate web site at
                     www.dyax.com
     Telephone:      (800) 238-9007
                     International callers, dial (719) 457-2622
                     Access code: 750508
 
     A replay of the conference call will be available for one week following
 the call and can be accessed by dialing (888) 203-1112.  International callers
 should dial (719) 457-0820.  The replay access code is 750508.  The Webcast
 will be archived on the Investor Relations page on Dyax's corporate web site
 at www.dyax.com.
     Dyax Corp. is a biopharmaceutical company that has developed and patented
 phage display technology with applications in the discovery and development of
 a broad range of compounds for the treatment and diagnosis of diseases and for
 the purification and manufacture of biopharmaceuticals and other chemicals.
 Through the use of phage display technology, Dyax's scientists, collaborators
 and licensees seek to discover peptides and proteins, including human
 antibodies, that bind tightly to specific molecular targets.  The Company,
 through a subsidiary, also develops, manufactures and sells chromatography
 separations systems and products under the Biotage trade name.
 
      Contact:
      Jessica Wolfe
      Director, Investor Relations
      Dyax Corp.
      (617) 225-2500
      jwolfe@dyax.com
 
      Doug MacDougall
      Kari Lampka
      Feinstein Kean Healthcare
      (617) 577-8110
      klampka@fkhealth.com
 
 SOURCE  Dyax Corp.